Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J22- Unspecified acute lower respiratory infection
Conditions
Interventions
Intervention1: AYURCOV: Following study medication is for one day
Investigational Product Gargle 2 times a day for one day
Investigational Product in half glass of warm water, to drink every 2 hours,
Sponsors
Bhaktivedanta Hospital and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1. COVID -19 Positive patients 2. Agree to consent for the study. 3. All Age groups above 18 Years 4. All genders.
Exclusion criteria
Exclusion criteria: 1. Unable to be followed-up during the trial 2. Current or future involvement in the active treatment phase of other interventional research studies (excluding observational/non-interventional studies) . 3. Any other clinical reason which may preclude entry in the opinion of the investigator. 4, Pregnant Women. 5. Patients who are on ventilator support .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COVID 19 FREE DISEASETimepoint: AT TIME OF DISCHARGE | — |
Secondary
| Measure | Time frame |
|---|---|
| SEVERITY OF COVID 19 DISEASETimepoint: DURING HOSPITALIZATION AND AT TIME OF DISCHARGE | — |
Countries
India
Contacts
Public ContactDr Nanasaheb Memane
Bhaktivedanta Hospital and Research Institute
Outcome results
None listed